AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35079088 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen/deuterium-exchange mass spectrometry (HDX-MS)
Number of subjects: 0
Study 32000375 — intervention group
Group type: EXPERIMENTAL
Intervention: Bloodletting device using the principle of 'prestimulation neurodisturbance' (RTLC, LTRC, RCLT, LCRT)
Number of subjects: 0
Study 32000375 — intervention group
Group type: COMPARATOR
Intervention: Control device (RTLC, LTRC, RCLT, LCRT)
Number of subjects: 0
Study 35772576 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated Radiotherapy (H‐RT) - 6000 cGy in 20 fractions over 4 weeks
Number of subjects: 222
Study 35772576 — intervention group
Group type: COMPARATOR
Intervention: Conventional Radiotherapy (C‐RT) - 7800 cGy in 39 fractions over 7 to 8 weeks
Number of subjects: 222
Study 35772576 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated Radiotherapy (H‐RT)
Number of subjects: 222
Study 35772576 — intervention group
Group type: COMPARATOR
Intervention: Conventional Radiotherapy (C‐RT)
Number of subjects: 222
Study 33885131 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate FET (performed in the first menstrual cycle following stimulated IVF)
Number of subjects: 724
Study 33885131 — intervention group
Group type: COMPARATOR
Intervention: Delayed FET (performed in the second or later menstrual cycle following stimulated IVF)
Number of subjects: 724
Study 32148083 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphocyte count
Number of subjects: 750000
Study 32148083 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocyte count
Number of subjects: 750000
Study 32148083 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophil count
Number of subjects: 750000
Study 32148083 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically elevated lymphocyte count
Number of subjects: 750000
Study 32148083 — intervention group
Group type: COMPARATOR
Intervention: Blood pressure indices
Number of subjects: 750000
Study 32148083 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphocyte count in context of genetic correlation with renal function
Number of subjects: 750000
Study 34554643 — intervention group
Group type: EXPERIMENTAL
Intervention: Visit-to-visit eGFR variability (EGV) in the derivation cohort (376 patients)
Number of subjects: 564
Study 34554643 — intervention group
Group type: EXPERIMENTAL
Intervention: Visit-to-visit eGFR variability (EGV)
Number of subjects: 564
Study 34554643 — intervention group
Group type: EXPERIMENTAL
Intervention: Models with EGV added to models with BNP or eGFR
Number of subjects: 564
Study 32286392 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese adolescents
Number of subjects: 431
Study 32286392 — intervention group
Group type: COMPARATOR
Intervention: Overweight adolescents
Number of subjects: 431
Study 32286392 — intervention group
Group type: COMPARATOR
Intervention: Normal-weight adolescents
Number of subjects: 431
Study 32286392 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall association
Number of subjects: 431
Study 33092326 — intervention group
Group type: EXPERIMENTAL
Intervention: Supramaximal efforts at 120% of MAP with oronasal mask (Supra<inf>mask</inf>)
Number of subjects: 24
Study 33092326 — intervention group
Group type: COMPARATOR
Intervention: Supramaximal efforts at 120% of MAP without oronasal mask (Supra<inf>be</inf>)
Number of subjects: 24
Study 32122914 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with Down syndrome (DS)
Number of subjects: 123
Study 34601410 — intervention group
Group type: EXPERIMENTAL
Intervention: Traffic-polluted road walking treatment
Number of subjects: 35
Study 34601410 — intervention group
Group type: COMPARATOR
Intervention: Traffic-free park walking treatment
Number of subjects: 35
Study 32208915 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation (CRYO) using a 9 F, 8 mm tip catheter (Freezor MAX, Medtronic, Inc, MN, USA)
Number of subjects: 184
Study 32208915 — intervention group
Group type: COMPARATOR
Intervention: Cryoablation (CRYO)
Number of subjects: 184
Study 35991781 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane (ESP) Block
Number of subjects: 60
Study 35991781 — intervention group
Group type: COMPARATOR
Intervention: PECS Block Type II
Number of subjects: 60
Study 32239201 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on presurgical variables
Number of subjects: 60766
Study 32239201 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on postsurgical variables
Number of subjects: 60766
Study 32239201 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall PORT delay
Number of subjects: 60766
Study 35999119 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant intravesical chemohyperthermia (CHT) with mitomycin C at 43°C
Number of subjects: 259
Study 35999119 — intervention group
Group type: COMPARATOR
Intervention: Room-temperature mitomycin C (control)
Number of subjects: 259
Study 35999119 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant intravesical chemohyperthermia (CHT)
Number of subjects: 259
Study 33838012 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (3MF)
Number of subjects: 3
Study 33838012 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-month community adherence groups (3MC)
Number of subjects: 3
Study 33838012 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-month community ART distribution (6MCD)
Number of subjects: 3
Study 35822730 — intervention group
Group type: EXPERIMENTAL
Intervention: Low pressure pneumoperitoneum (8 mm Hg) with deep neuromuscular blockade (posttetanic count 1-2)
Number of subjects: 178
Study 35822730 — intervention group
Group type: COMPARATOR
Intervention: Standard pressure pneumoperitoneum (12 mm Hg) with moderate neuromuscular blockade (train-of-four 1-2)
Number of subjects: 178
Study 35822730 — intervention group
Group type: EXPERIMENTAL
Intervention: Low pressure pneumoperitoneum
Number of subjects: 178
Study 34369692 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture with Tiaoshen Jianpi for IBS-C
Number of subjects: 519
Study 34369692 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG) for IBS-C
Number of subjects: 519
Study 34369692 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture with Tiaoshen Jianpi for IBS-D
Number of subjects: 519
Study 34369692 — intervention group
Group type: COMPARATOR
Intervention: Pinaverium for IBS-D
Number of subjects: 519
Study 34369692 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IBS-C and IBS-D)
Number of subjects: 519
Study 34966064 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Rehabilitation (PFR)
Number of subjects: 128
Study 34966064 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 128
Study 33766805 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep disturbance (self-reported)
Number of subjects: 1099
Study 33766805 — intervention group
Group type: EXPERIMENTAL
Intervention: Worst sleep disturbance
Number of subjects: 1099
Study 33766805 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep disturbance in women
Number of subjects: 1099
Study 33766805 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep disturbance
Number of subjects: 1099
Study 32887557 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 L/min O2
Number of subjects: 443
Study 32887557 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 443
Study 33179154 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting mimicking diet (FMD)
Number of subjects: 131
Study 33179154 — intervention group
Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 131
Study 32359741 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg/day curcuminoids
Number of subjects: 80
Study 32359741 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000 IU/week vitamin D3
Number of subjects: 80
Study 32359741 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000 IU/week vitamin D3 plus 500 mg/day curcuminoids
Number of subjects: 80
Study 32359741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 34871182 — intervention group
Group type: EXPERIMENTAL
Intervention: CERC-002 (human LIGHT-neutralizing antibody)
Number of subjects: 83
Study 34871182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 34871182 — intervention group
Group type: EXPERIMENTAL
Intervention: CERC-002
Number of subjects: 83
Study 35926886 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow diversion
Number of subjects: 323
Study 35926886 — intervention group
Group type: COMPARATOR
Intervention: Alternative standard management options
Number of subjects: 323
Study 32722015 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (EG) - dairy preparation enriched in calcium, vitamin D, vitamin K, vitamin C, zinc, magnesium, L‐leucine and probiotic (Lactobacillus plantarum 3547) consumed daily for 24 weeks
Number of subjects: 78
Study 32722015 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (EG)
Number of subjects: 78
Study 35312857 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) therapy
Number of subjects: 32
Study 35312857 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 32
Study 32611284 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase (0.9 mg/kg)
Number of subjects: 1028
Study 32611284 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1028
Study 36280804 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-free anesthesia (OFA) regimen including IV magnesium sulfate, lidocaine, ketamine, dexamethasone, propofol, rocuronium, isoflurane, and continuous infusion of magnesium sulfate, ketamine, and clonidine
Number of subjects: 36
Study 36280804 — intervention group
Group type: COMPARATOR
Intervention: Conventional general anesthesia (CGA) regimen including IV dexamethasone, diazepam, fentanyl, propofol, rocuronium, isoflurane, and reinjections of fentanyl and propofol with normal saline as placebo
Number of subjects: 36
Study 34763495 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal 3D ultrasound combined with color Doppler ultrasound
Number of subjects: 0
Study 34763495 — intervention group
Group type: COMPARATOR
Intervention: Transvaginal 3D ultrasound
Number of subjects: 0
Study 36263942 — intervention group
Group type: EXPERIMENTAL
Intervention: L-theanine 100 mg
Number of subjects: 32
Study 36263942 — intervention group
Group type: EXPERIMENTAL
Intervention: L-theanine 200 mg
Number of subjects: 32
Study 36263942 — intervention group
Group type: EXPERIMENTAL
Intervention: L-theanine 200 mg to 400 mg
Number of subjects: 32
Study 36263942 — intervention group
Group type: COMPARATOR
Intervention: Placebo (distilled water)
Number of subjects: 32
Study 33280989 — intervention group
Group type: EXPERIMENTAL
Intervention: One trapezoidal plate
Number of subjects: 52
Study 33280989 — intervention group
Group type: COMPARATOR
Intervention: Two miniplates
Number of subjects: 52
Study 35946245 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional brackets with Connecticut New Archwire (CNA) wire mushroom loop
Number of subjects: 80
Study 35946245 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional brackets with TAD (AbsoAnchor, Korea) supported retraction
Number of subjects: 80
Study 35946245 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive SLB with CNA archwires (Libral Traders, India) mushroom loop
Number of subjects: 80
Study 35946245 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive SLB brackets with TAD (AbsoAnchor, Korea) supported retraction
Number of subjects: 80
Study 35946245 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study 34514770 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine infusion of PRP (0.5CC, contained platelet 4-5 times more than a peripheral blood sample, performed 48 hours before blastocyst transfer)
Number of subjects: 100
Study 34514770 — intervention group
Group type: COMPARATOR
Intervention: Intrauterine catheterization only (control)
Number of subjects: 100
Study 35644166 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 45 mg once daily (induction)
Number of subjects: 1447
Study 35644166 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg (maintenance)
Number of subjects: 1447
Study 35644166 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 30 mg (maintenance)
Number of subjects: 1447
Study 35644166 — intervention group
Group type: COMPARATOR
Intervention: Placebo (induction)
Number of subjects: 1447
Study 35644166 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maintenance)
Number of subjects: 1447
Study 32591257 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered decision aid (DA) written at a 7th grade reading level
Number of subjects: 0
Study 32591257 — intervention group
Group type: COMPARATOR
Intervention: Standard decision aid (DA) written at >9th grade reading level
Number of subjects: 0
Study 32591257 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered decision aid (DA)
Number of subjects: 0
Study 32591257 — intervention group
Group type: COMPARATOR
Intervention: Standard decision aid (DA)
Number of subjects: 0
Study 36040444 — intervention group
Group type: COMPARATOR
Intervention: Biovalorized okara (RO)
Number of subjects: 15
Study 36040444 — intervention group
Group type: COMPARATOR
Intervention: Okara (AOK)
Number of subjects: 15
Study 34733346 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate physical activity program (12 weeks, 3 sessions per week)
Number of subjects: 105
Study 34733346 — intervention group
Group type: COMPARATOR
Intervention: Cultural and recreational activities (control condition)
Number of subjects: 105
Study 32618383 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotagliflozin 200 mg
Number of subjects: 1575
Study 32618383 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotagliflozin 400 mg
Number of subjects: 1575
Study 32618383 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1575
Study 36280932 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 120
Study 36280932 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 120
Study 33277168 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanolin and health education on breastfeeding
Number of subjects: 66
Study 33277168 — intervention group
Group type: COMPARATOR
Intervention: Standard health education
Number of subjects: 66
Study 35285995 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional Candida antigen
Number of subjects: 120
Study 35285995 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional PPD
Number of subjects: 120
Study 35285995 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 120
Study 32860734 — intervention group
Group type: EXPERIMENTAL
Intervention: Bardoxolone methyl
Number of subjects: 2185
Study 32860734 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2185
Study 32963066 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternally administered malnutrition monitoring system (MAMMS) with SMS prompts for MUAC measurement.
Number of subjects: 1200
Study 32963066 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) with routine monitoring by community health volunteers and quarterly visits from study staff.
Number of subjects: 1200
Study 32963066 — intervention group
Group type: EXPERIMENTAL
Intervention: MAMMS
Number of subjects: 1200
Study 36176092 — intervention group
Group type: EXPERIMENTAL
Intervention: AGREE rehabilitation platform
Number of subjects: 0
Study 36176092 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33720873 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stabilization exercises combined with the Asthma Education Program (AEP) and breathing exercises
Number of subjects: 40
Study 33720873 — intervention group
Group type: COMPARATOR
Intervention: Asthma Education Program (AEP) and breathing exercises
Number of subjects: 40
Study 32427228 — intervention group
Group type: EXPERIMENTAL
Intervention: Squeeze bottle nasal saline irrigation
Number of subjects: 116
Study 32427228 — intervention group
Group type: COMPARATOR
Intervention: Syringe nasal saline irrigation
Number of subjects: 116
Study 35478978 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical exercise (neck extension isometric muscle strengthening and cervical ROM exercises) for 3 months starting on postoperative day 2
Number of subjects: 61
Study 35478978 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise (control group)
Number of subjects: 61
Study 35478978 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical exercise
Number of subjects: 61
Study 35817320 — intervention group
Group type: EXPERIMENTAL
Intervention: SPLS-IMRT
Number of subjects: 90
Study 35817320 — intervention group
Group type: COMPARATOR
Intervention: C-IMRT
Number of subjects: 90
Study 34836277 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule containing spray-dried powder from pineapple juice broth fermented with Lactobacillus paracasei IJH-SONE68, taken daily for 12 weeks
Number of subjects: 60
Study 34836277 — intervention group
Group type: COMPARATOR
Intervention: Placebo, taken daily for 12 weeks
Number of subjects: 60
Study 34836277 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule containing spray-dried powder from pineapple juice broth fermented with Lactobacillus paracasei IJH-SONE68
Number of subjects: 60
Study 34836277 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32103364 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmentation-independent volume rendering (SI-VR)
Number of subjects: 220
Study 32103364 — intervention group
Group type: COMPARATOR
Intervention: 3D fast spin echo T2WI
Number of subjects: 220
Study 35244040 — intervention group
Group type: EXPERIMENTAL
Intervention: Long manipulation combined with sling exercise training (SET)
Number of subjects: 90
Study 35244040 — intervention group
Group type: EXPERIMENTAL
Intervention: Long manipulation
Number of subjects: 90
Study 35244040 — intervention group
Group type: COMPARATOR
Intervention: Conventional massage
Number of subjects: 90
Study 32209647 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster aspart
Number of subjects: 1091
Study 32209647 — intervention group
Group type: COMPARATOR
Intervention: IAsp
Number of subjects: 1091
Study 35552172 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation combined with routine treatment
Number of subjects: 60
Study 35552172 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment only (positive control group)
Number of subjects: 60
Study 35552172 — intervention group
Group type: EXPERIMENTAL
Intervention: MicroR-423-5p
Number of subjects: 60
Study 35552172 — intervention group
Group type: EXPERIMENTAL
Intervention: N-terminal pro-B-type natriuretic peptide
Number of subjects: 60
Study 36459138 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose erythropoietin (2000 units/kg body weight)
Number of subjects: 121
Study 36459138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 36459138 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose erythropoietin
Number of subjects: 121
Study 33720755 — intervention group
Group type: EXPERIMENTAL
Intervention: Burnout assessment via validated survey instruments
Number of subjects: 132
Study 33720755 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative interviews
Number of subjects: 132
Study 33720755 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal demand assessment
Number of subjects: 132
Study 32558052 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold exposure
Number of subjects: 20
Study 32558052 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron (200 mg one dose p.o.)
Number of subjects: 20
Study 32558052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 35485627 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits (four 60-minute sessions once a week)
Number of subjects: 114
Study 35485627 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up (four 30-minute sessions twice a week for a month)
Number of subjects: 114
Study 35485627 — intervention group
Group type: COMPARATOR
Intervention: Control (routine care)
Number of subjects: 114
Study 35485627 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits
Number of subjects: 114
Study 35485627 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up
Number of subjects: 114
Study 34989412 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nasal anesthetic (TNA) - viscous lidocaine
Number of subjects: 20
Study 34989412 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 34989412 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TNA and placebo
Number of subjects: 20
Study 33915390 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT)
Number of subjects: 0
Study 33915390 — intervention group
Group type: COMPARATOR
Intervention: No endovascular therapy (no-EVT)
Number of subjects: 0
Study 32003938 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg + amlodipine 10 mg
Number of subjects: 106
Study 32003938 — intervention group
Group type: COMPARATOR
Intervention: amlodipine 10 mg
Number of subjects: 106
Study 32003938 — intervention group
Group type: COMPARATOR
Intervention: rosuvastatin 20 mg
Number of subjects: 106
Study 35809091 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 60% of individual anaerobic threshold
Number of subjects: 25
Study 35809091 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 80% of individual anaerobic threshold
Number of subjects: 25
Study 35809091 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 100% of individual anaerobic threshold
Number of subjects: 25
Study 35809091 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 110% of individual anaerobic threshold
Number of subjects: 25
Study 35809091 — intervention group
Group type: EXPERIMENTAL
Intervention: All exercise intensities
Number of subjects: 25
Study 33773639 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Safe app (intervention arm)
Number of subjects: 700
Study 33773639 — intervention group
Group type: COMPARATOR
Intervention: Attention control medication list app (control arm)
Number of subjects: 700
Study 36138363 — intervention group
Group type: EXPERIMENTAL
Intervention: SaCoVLM™ video laryngeal mask-guided intubation
Number of subjects: 120
Study 36138363 — intervention group
Group type: COMPARATOR
Intervention: i-gel combined with flexible bronchoscopy-guided intubation
Number of subjects: 120